Growing evidence suggests that the United States is entering another period of rapidly rising health care expenditures. PHSI is currently supporting several projects that it believes will add important perspectives for future policy discussions as containing health care costs becomes an increasingly important policy agenda item.
National Health Accounts
Building on initial work to develop a measure of adult population health, David Cutler and his collaborator Allison Rosen are developing a revised set of National Health Accounts that will provide a systematic view of the benefits, as well as the costs of health care. These revised accounts will include information on population health, to allow for an ongoing picture of the value of our national health spending. This effort includes disease-specific modeling for those diseases that have the biggest impact on health (high prevalence, morbidity, and/or mortality) and/or health care expenditures. The purpose is to determine the cost of these diseases now and in the past, and the change in population health from these conditions. The overall goal of this project is to generate a set of revised National Health Accounts that will be produced regularly and published by the Federal government, and used to inform health care policy.
Consequences of Biomedical Innovation on Health Care Spending
In April 2004 PHSI sponsored a conference on Reassessing the Value Equation: Consequences of Biomedical Innovation and Health Care Spending. The meeting included three panels of health care researchers who addressed major issues related to health care value, including calculating the return on investment in health care services, identifying health care technologies that have cost-effectively impacted disease prevention and treatment, and evaluating the economic consequences of health care spending and biomedical research for local, national, and global economies. Conference Summary
Cost Effectiveness and Cost Utility
PHSI supported the work of Peter Neumann to include non-health care interventions in an expanded Cost-Effectiveness Registry. Dr. Neumann and colleagues collaborated with researchers in diverse fields to assess the cost-effectiveness of interventions that do not involve the direct provision of medical services to facilitate their comparison with explicitly medical interventions.
Dr. Neumann's 2005 article on cost-utility analyses: Can We Better Prioritize Resources for Cost-Utility Research? Medical Decision Making. Vol. 25, No. 4, 429-436 (2005).